by Rakovina Therapeutics | Jun 3, 2026 | Uncategorized
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, June 1, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through...
by Rakovina Therapeutics | Jun 1, 2026 | Uncategorized
DOWNLOAD All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, June 1, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies...
by Rakovina Therapeutics | Apr 30, 2026 | Uncategorized
download VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, today announced its financial...
by Rakovina Therapeutics | Apr 22, 2026 | Uncategorized
DOWNLOAD AI-Designed Dual ATR-mTOR Inhibitor Demonstrates In Vivo Efficacy; Novel LNP Formulation of Bifunctional PARP/HDAC Inhibitor kt-3283 Successfully Characterized VANCOUVER, British Columbia, April 22, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc....
by Rakovina Therapeutics | Mar 23, 2026 | Uncategorized
Accepted Abstracts Highlight Advances in AI-Driven Oncology Pipeline DOWNLOAD VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies...